TCIM
OSIR
TIAA CREF Investment Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-52,276
| Closed | -$257K | – | 3140 |
|
|
2016
Q4 | $257K | Sell |
52,276
-13,608
| -21% | -$66.9K | ﹤0.01% | 3006 |
|
|
2016
Q3 | $327 | Hold |
65,884
| – | – | ﹤0.01% | 2981 |
|
|
2016
Q2 | $335K | Buy |
65,884
+5,209
| +9% | +$26.5K | ﹤0.01% | 3006 |
|
|
2016
Q1 | $346K | Buy |
60,675
+4,121
| +7% | +$23.5K | ﹤0.01% | 2887 |
|
|
2015
Q4 | $587K | Sell |
56,554
-2,708
| -5% | -$28.1K | ﹤0.01% | 2841 |
|
|
2015
Q3 | $1.1M | Hold |
59,262
| – | – | ﹤0.01% | 2523 |
|
|
2015
Q2 | $1.15M | Buy |
59,262
+452
| +0.8% | +$8.79K | ﹤0.01% | 2627 |
|
|
2015
Q1 | $1.03M | Hold |
58,810
| – | – | ﹤0.01% | 2601 |
|
|
2014
Q4 | $940K | Sell |
58,810
-9,341
| -14% | -$149K | ﹤0.01% | 2681 |
|
|
2014
Q3 | $858K | Sell |
68,151
-4,091
| -6% | -$51.5K | ﹤0.01% | 2724 |
|
|
2014
Q2 | $1.13M | Buy |
72,242
+34
| +0% | +$531 | ﹤0.01% | 2649 |
|
|
2014
Q1 | $948K | Sell |
72,208
-2,330
| -3% | -$30.6K | ﹤0.01% | 2667 |
|
|
2013
Q4 | $1.2M | Buy |
74,538
+6,270
| +9% | +$101K | ﹤0.01% | 2567 |
|
|
2013
Q3 | $1.14M | Sell |
68,268
-355
| -0.5% | -$5.91K | ﹤0.01% | 2543 |
|
|
2013
Q2 | $691K | Buy |
+68,623
| New | +$691K | ﹤0.01% | 2804 |
|